Goldstein J, Lehnhardt S, Inouye M
Department of Biochemistry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway 08854-5635.
J Biol Chem. 1991 Aug 5;266(22):14413-7.
On the basis of the biophysical studies on the synthetic mutant (Ile-8----Asn) OmpA signal peptide in the preceding paper (Hoyt, D. C., and Gierasch, L.M. (1991) J. Biol. Chem. 266, 14406-14412), the in vivo effects of the same mutation were examined by fusing the mutant OmpA signal sequence to Staphylococcus aureus nuclease or TEM beta-lactamase. The mutation in which the isoleucine residue at position 8 of the OmpA signal sequence of Escherichia coli was replaced with a neutral polar residue, asparagine, resulted in a defective signal peptide. The mutant signal sequence was unable to be processed, and the precursor molecule accumulated in the cytoplasmic as well as in the membrane fractions, indicating that the Ile-8----Asn OmpA signal sequence is not competent for translocating nuclease A or beta-lactamase across the membrane. This result is consistent with the in vitro studies on the Ile-8----Asn OmpA signal peptide, which indicated that the mutant signal peptide was unable to penetrate into the hydrophobic core of the lipid bilayer. Other asparagine or glutamine substitution mutations in the hydrophobic region of the OmpA signal sequence were also examined. Interestingly, the OmpA signal sequence with either Ile-8----Gln, Val-10----Asn, or Leu-12----Asn mutation was completely defective as the Ile-8----Asn OmpA signal sequence, while the Ile-6----Asn and Ala-9----Asn OmpA nucleases were able to be processed to secrete nuclease, although the processing occurred at a much slower rate than the wild-type OmpA nuclease. These results indicate that the defects depend on the position of the lesion in the hydrophobic core of the OmpA signal sequence.
基于前文(霍伊特,D.C.,和吉拉施,L.M.(1991年)《生物化学杂志》266卷,第14406 - 14412页)对合成突变体(异亮氨酸-8→天冬酰胺)OmpA信号肽的生物物理研究,通过将突变的OmpA信号序列与金黄色葡萄球菌核酸酶或TEMβ-内酰胺酶融合,检测了相同突变在体内的影响。大肠杆菌OmpA信号序列第8位的异亮氨酸残基被中性极性残基天冬酰胺取代的突变,产生了有缺陷的信号肽。突变的信号序列无法被加工,前体分子在细胞质以及膜组分中积累,表明异亮氨酸-8→天冬酰胺OmpA信号序列无能力将核酸酶A或β-内酰胺酶转运穿过膜。这一结果与对异亮氨酸-8→天冬酰胺OmpA信号肽的体外研究一致,体外研究表明突变的信号肽无法穿透脂质双层的疏水核心。还检测了OmpA信号序列疏水区域的其他天冬酰胺或谷氨酰胺取代突变。有趣的是,具有异亮氨酸-8→谷氨酰胺、缬氨酸-10→天冬酰胺或亮氨酸-12→天冬酰胺突变的OmpA信号序列与异亮氨酸-8→天冬酰胺OmpA信号序列一样完全有缺陷,而异亮氨酸-6→天冬酰胺和丙氨酸-9→天冬酰胺OmpA核酸酶能够被加工以分泌核酸酶,尽管加工速度比野生型OmpA核酸酶慢得多。这些结果表明缺陷取决于病变在OmpA信号序列疏水核心中的位置。